Trials find new combination regimen extends survival
Cleveland Clinic study focuses on outpatient transition
Cleveland Clinic study: Drugs lacking for actionable targets
Cleveland Clinic study sees benefit for NSCLC patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers see patient subgroups with higher clot risk
Researchers plan future trials to validate study results
What role does treatment value play in a care path?
Studies also address survivorship issues
Can a standardized care path accommodate cancer’s individualized genomic variations?
Many countries have significant obstacles
Advertisement
Advertisement